_id
69130c72ccc777a4e85d7d04
Ticker
KZR
Name
Kezar Life Sciences Inc
Exchange
NASDAQ
Address
4000 Shoreline Court, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.kezarlifesciences.com
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Last Close
6.35
Volume
26013
Current Price
6.25
Change
-1.5748031496062938
Last Updated
2025-12-01T10:05:20.186Z
Image
-
Ipo Date
2018-06-21T00:00:00.000Z
Market Cap
45403564
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
6
Strong Buy
3
Buy
0
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
227000
Gross Profit
-227000
Operating Expenses
11488000
Operating Income
-11715000
Interest Expense
538000
Pretax Income
-11227000
Net Income
-11227000
Eps
-1.5330926522161499
Dividends Per Share
-
Shares Outstanding
7323156
Income Tax Expense
-
EBITDA
-11000000
Operating Margin
-
Total Other Income Expense Net
488000
Cash
38935000
Short Term Investments
51281000
Receivables
2001999
Inventories
-
Total Current Assets
94501000
Property Plant Equipment
3225000
Total Assets
97726000
Payables
911000
Short Term Debt
8538000
Long Term Debt
1374000
Total Liabilities
14750000
Equity
82976000
Depreciation
227000
Change In Working Capital
-787000
Cash From Operations
-9830000
Capital Expenditures
0
Cash From Investing
15712000
Cash From Financing
-1305000
Net Change In Cash
4568000
PE
-
PB
0.5515982030948708
ROE
-13.530418434246046
ROA
-11.488242637578535
FCF
-9830000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
5
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
227000
Quarters > 0 > income Statement > gross Profit
-227000
Quarters > 0 > income Statement > operating Expenses
11488000
Quarters > 0 > income Statement > operating Income
-11715000
Quarters > 0 > income Statement > interest Expense
538000
Quarters > 0 > income Statement > pretax Income
-11227000
Quarters > 0 > income Statement > net Income
-11227000
Quarters > 0 > income Statement > eps
-1.5330926522161499
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7323106
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-11000000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
488000
Quarters > 0 > balance Sheet > cash
38935000
Quarters > 0 > balance Sheet > short Term Investments
51281000
Quarters > 0 > balance Sheet > receivables
2001999
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
94501000
Quarters > 0 > balance Sheet > property Plant Equipment
3225000
Quarters > 0 > balance Sheet > total Assets
97726000
Quarters > 0 > balance Sheet > payables
911000
Quarters > 0 > balance Sheet > short Term Debt
8538000
Quarters > 0 > balance Sheet > long Term Debt
1374000
Quarters > 0 > balance Sheet > total Liabilities
14750000
Quarters > 0 > balance Sheet > equity
82976000
Quarters > 0 > cash Flow > net Income
-11227000
Quarters > 0 > cash Flow > depreciation
227000
Quarters > 0 > cash Flow > change In Working Capital
-787000
Quarters > 0 > cash Flow > cash From Operations
-9830000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
15712000
Quarters > 0 > cash Flow > cash From Financing
-1305000
Quarters > 0 > cash Flow > net Change In Cash
4568000
Quarters > 0 > ratios > PE
-1.5330926522161499
Quarters > 0 > ratios > PB
0.5515982030948708
Quarters > 0 > ratios > ROE
-13.530418434246046
Quarters > 0 > ratios > ROA
-11.488242637578535
Quarters > 0 > ratios > FCF
-9830000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
14599000
Quarters > 1 > income Statement > operating Income
-14599000
Quarters > 1 > income Statement > interest Expense
302000
Quarters > 1 > income Statement > pretax Income
-13704000
Quarters > 1 > income Statement > net Income
-13704000
Quarters > 1 > income Statement > eps
-1.8744275773926307
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
7311032
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-13159000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
895000
Quarters > 1 > balance Sheet > cash
34367000
Quarters > 1 > balance Sheet > short Term Investments
66482000
Quarters > 1 > balance Sheet > receivables
1995000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
104702000
Quarters > 1 > balance Sheet > property Plant Equipment
3747000
Quarters > 1 > balance Sheet > total Assets
109123000
Quarters > 1 > balance Sheet > payables
1157000
Quarters > 1 > balance Sheet > short Term Debt
9101000
Quarters > 1 > balance Sheet > long Term Debt
2628000
Quarters > 1 > balance Sheet > total Liabilities
17337000
Quarters > 1 > balance Sheet > equity
91786000
Quarters > 1 > cash Flow > net Income
-13704000
Quarters > 1 > cash Flow > depreciation
-344000
Quarters > 1 > cash Flow > change In Working Capital
-1210000
Quarters > 1 > cash Flow > cash From Operations
-12795000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
11397000
Quarters > 1 > cash Flow > cash From Financing
-1269000
Quarters > 1 > cash Flow > net Change In Cash
-2635000
Quarters > 1 > ratios > PE
-1.8744275773926307
Quarters > 1 > ratios > PB
0.49783136861830785
Quarters > 1 > ratios > ROE
-14.930381539668359
Quarters > 1 > ratios > ROA
-12.558305765054111
Quarters > 1 > ratios > FCF
-12795000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
251000
Quarters > 2 > income Statement > gross Profit
-251000
Quarters > 2 > income Statement > operating Expenses
17629000
Quarters > 2 > income Statement > operating Income
-17629000
Quarters > 2 > income Statement > interest Expense
347000
Quarters > 2 > income Statement > pretax Income
-16556000
Quarters > 2 > income Statement > net Income
-16556000
Quarters > 2 > income Statement > eps
-2.2661887539767123
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
7305658
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-15958000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1073000
Quarters > 2 > balance Sheet > cash
37002000
Quarters > 2 > balance Sheet > short Term Investments
77359000
Quarters > 2 > balance Sheet > receivables
2199000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
120318000
Quarters > 2 > balance Sheet > property Plant Equipment
4268000
Quarters > 2 > balance Sheet > total Assets
125260000
Quarters > 2 > balance Sheet > payables
1966000
Quarters > 2 > balance Sheet > short Term Debt
8882000
Quarters > 2 > balance Sheet > long Term Debt
3874000
Quarters > 2 > balance Sheet > total Liabilities
22191000
Quarters > 2 > balance Sheet > equity
103069000
Quarters > 2 > cash Flow > net Income
-16556000
Quarters > 2 > cash Flow > depreciation
251000
Quarters > 2 > cash Flow > change In Working Capital
-3135000
Quarters > 2 > cash Flow > cash From Operations
-17190000
Quarters > 2 > cash Flow > capital Expenditures
8000
Quarters > 2 > cash Flow > cash From Investing
13742000
Quarters > 2 > cash Flow > cash From Financing
-1304000
Quarters > 2 > cash Flow > net Change In Cash
-4747000
Quarters > 2 > ratios > PE
-2.2661887539767123
Quarters > 2 > ratios > PB
0.44300771813057277
Quarters > 2 > ratios > ROE
-16.063025740038228
Quarters > 2 > ratios > ROA
-13.217307999361328
Quarters > 2 > ratios > FCF
-17198000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1042000
Quarters > 3 > income Statement > cost Of Revenue
259000
Quarters > 3 > income Statement > gross Profit
521000
Quarters > 3 > income Statement > operating Expenses
21563000
Quarters > 3 > income Statement > operating Income
-21563000
Quarters > 3 > income Statement > interest Expense
389000
Quarters > 3 > income Statement > pretax Income
-20218000
Quarters > 3 > income Statement > net Income
-20218000
Quarters > 3 > income Statement > eps
-2.7695863853281235
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
7300007
Quarters > 3 > income Statement > income Tax Expense
-216724
Quarters > 3 > income Statement > EBITDA
-19570000
Quarters > 3 > income Statement > operating Margin
-2069.3857965451057
Quarters > 3 > income Statement > total Other Income Expense Net
1345000
Quarters > 3 > balance Sheet > cash
41749000
Quarters > 3 > balance Sheet > short Term Investments
90496000
Quarters > 3 > balance Sheet > receivables
424000
Quarters > 3 > balance Sheet > inventories
514000
Quarters > 3 > balance Sheet > total Current Assets
137488000
Quarters > 3 > balance Sheet > property Plant Equipment
4779000
Quarters > 3 > balance Sheet > total Assets
144682000
Quarters > 3 > balance Sheet > payables
3651000
Quarters > 3 > balance Sheet > short Term Debt
8743000
Quarters > 3 > balance Sheet > long Term Debt
5111000
Quarters > 3 > balance Sheet > total Liabilities
27766000
Quarters > 3 > balance Sheet > equity
116916000
Quarters > 3 > cash Flow > net Income
-20218000
Quarters > 3 > cash Flow > depreciation
259000
Quarters > 3 > cash Flow > change In Working Capital
668000
Quarters > 3 > cash Flow > cash From Operations
-16825000
Quarters > 3 > cash Flow > capital Expenditures
11000
Quarters > 3 > cash Flow > cash From Investing
23744000
Quarters > 3 > cash Flow > cash From Financing
47000
Quarters > 3 > cash Flow > net Change In Cash
6891000
Quarters > 3 > ratios > PE
-2.7695863853281235
Quarters > 3 > ratios > PB
0.3902378096240035
Quarters > 3 > ratios > ROE
-17.292757193198536
Quarters > 3 > ratios > ROA
-13.97409491159923
Quarters > 3 > ratios > FCF
-16836000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-16.157389635316697
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1040000
Annuals > 0 > income Statement > gross Profit
-1040000
Annuals > 0 > income Statement > operating Expenses
90605000
Annuals > 0 > income Statement > operating Income
-90605000
Annuals > 0 > income Statement > interest Expense
1593000
Annuals > 0 > income Statement > pretax Income
-83736000
Annuals > 0 > income Statement > net Income
-83736000
Annuals > 0 > income Statement > eps
-1.1486033734120047
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
72902450
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-81103000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
6869000
Annuals > 0 > balance Sheet > cash
41749000
Annuals > 0 > balance Sheet > short Term Investments
90496000
Annuals > 0 > balance Sheet > receivables
424000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
137488000
Annuals > 0 > balance Sheet > property Plant Equipment
4779000
Annuals > 0 > balance Sheet > total Assets
144682000
Annuals > 0 > balance Sheet > payables
3651000
Annuals > 0 > balance Sheet > short Term Debt
8743000
Annuals > 0 > balance Sheet > long Term Debt
5111000
Annuals > 0 > balance Sheet > total Liabilities
27766000
Annuals > 0 > balance Sheet > equity
116916000
Annuals > 0 > cash Flow > net Income
-83736000
Annuals > 0 > cash Flow > depreciation
1040000
Annuals > 0 > cash Flow > change In Working Capital
-1300000
Annuals > 0 > cash Flow > cash From Operations
-74212000
Annuals > 0 > cash Flow > capital Expenditures
29000
Annuals > 0 > cash Flow > cash From Investing
80428000
Annuals > 0 > cash Flow > cash From Financing
103000
Annuals > 0 > cash Flow > net Change In Cash
6256000
Annuals > 0 > ratios > PE
-1.1486033734120047
Annuals > 0 > ratios > PB
3.865982329193609
Annuals > 0 > ratios > ROE
-71.62065072359643
Annuals > 0 > ratios > ROA
-57.87589333849408
Annuals > 0 > ratios > FCF
-74241000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
7000000
Annuals > 1 > income Statement > cost Of Revenue
1066000
Annuals > 1 > income Statement > gross Profit
7000000
Annuals > 1 > income Statement > operating Expenses
118424000
Annuals > 1 > income Statement > operating Income
-111424000
Annuals > 1 > income Statement > interest Expense
1550000
Annuals > 1 > income Statement > pretax Income
-101870000
Annuals > 1 > income Statement > net Income
-101870000
Annuals > 1 > income Statement > eps
-1.40406453735026
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
72553645
Annuals > 1 > income Statement > income Tax Expense
898105
Annuals > 1 > income Statement > EBITDA
-99254000
Annuals > 1 > income Statement > operating Margin
-1591.7714285714287
Annuals > 1 > income Statement > total Other Income Expense Net
9554000
Annuals > 1 > balance Sheet > cash
35493000
Annuals > 1 > balance Sheet > short Term Investments
165879000
Annuals > 1 > balance Sheet > receivables
2291000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
206950000
Annuals > 1 > balance Sheet > property Plant Equipment
8690000
Annuals > 1 > balance Sheet > total Assets
221235000
Annuals > 1 > balance Sheet > payables
8250999
Annuals > 1 > balance Sheet > short Term Debt
3012000
Annuals > 1 > balance Sheet > long Term Debt
10069000
Annuals > 1 > balance Sheet > total Liabilities
33665000
Annuals > 1 > balance Sheet > equity
187570000
Annuals > 1 > cash Flow > net Income
-101870000
Annuals > 1 > cash Flow > depreciation
1066000
Annuals > 1 > cash Flow > change In Working Capital
4706000
Annuals > 1 > cash Flow > cash From Operations
-81645000
Annuals > 1 > cash Flow > capital Expenditures
1810000
Annuals > 1 > cash Flow > cash From Investing
76046000
Annuals > 1 > cash Flow > cash From Financing
638000
Annuals > 1 > cash Flow > net Change In Cash
-4963000
Annuals > 1 > ratios > PE
-1.40406453735026
Annuals > 1 > ratios > PB
2.3982118622380977
Annuals > 1 > ratios > ROE
-54.31039078743935
Annuals > 1 > ratios > ROA
-46.04605961986123
Annuals > 1 > ratios > FCF
-83455000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-11.922142857142857
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1022999
Annuals > 2 > income Statement > gross Profit
-1022999
Annuals > 2 > income Statement > operating Expenses
71162000
Annuals > 2 > income Statement > operating Income
-71162000
Annuals > 2 > income Statement > interest Expense
1185000
Annuals > 2 > income Statement > pretax Income
-68239000
Annuals > 2 > income Statement > net Income
-65316000
Annuals > 2 > income Statement > eps
-0.9695269785695736
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
67368935
Annuals > 2 > income Statement > income Tax Expense
-2923000
Annuals > 2 > income Statement > EBITDA
-70139000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2923000
Annuals > 2 > balance Sheet > cash
40456000
Annuals > 2 > balance Sheet > short Term Investments
236105000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
285722000
Annuals > 2 > balance Sheet > property Plant Equipment
13172000
Annuals > 2 > balance Sheet > total Assets
299568000
Annuals > 2 > balance Sheet > payables
2479000
Annuals > 2 > balance Sheet > short Term Debt
2565000
Annuals > 2 > balance Sheet > long Term Debt
9834000
Annuals > 2 > balance Sheet > total Liabilities
29696000
Annuals > 2 > balance Sheet > equity
269872000
Annuals > 2 > cash Flow > net Income
-68239000
Annuals > 2 > cash Flow > depreciation
1023000
Annuals > 2 > cash Flow > change In Working Capital
-4459000
Annuals > 2 > cash Flow > cash From Operations
-58846000
Annuals > 2 > cash Flow > capital Expenditures
1578000
Annuals > 2 > cash Flow > cash From Investing
-91392000
Annuals > 2 > cash Flow > cash From Financing
127861000
Annuals > 2 > cash Flow > net Change In Cash
-22426000
Annuals > 2 > ratios > PE
-0.9695269785695736
Annuals > 2 > ratios > PB
1.5477240951265787
Annuals > 2 > ratios > ROE
-24.202584929151598
Annuals > 2 > ratios > ROA
-21.803396891523793
Annuals > 2 > ratios > FCF
-60424000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1510000
Annuals > 3 > income Statement > gross Profit
-1510000
Annuals > 3 > income Statement > operating Expenses
53149000
Annuals > 3 > income Statement > operating Income
-54659000
Annuals > 3 > income Statement > interest Expense
159000
Annuals > 3 > income Statement > pretax Income
-54630000
Annuals > 3 > income Statement > net Income
-54630000
Annuals > 3 > income Statement > eps
-1.0354565689654731
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
52759335
Annuals > 3 > income Statement > income Tax Expense
-1351000
Annuals > 3 > income Statement > EBITDA
-52961000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
29000
Annuals > 3 > balance Sheet > cash
62882000
Annuals > 3 > balance Sheet > short Term Investments
145473000
Annuals > 3 > balance Sheet > receivables
70000
Annuals > 3 > balance Sheet > inventories
2500000
Annuals > 3 > balance Sheet > total Current Assets
211654000
Annuals > 3 > balance Sheet > property Plant Equipment
5997000
Annuals > 3 > balance Sheet > total Assets
217933000
Annuals > 3 > balance Sheet > payables
2028000
Annuals > 3 > balance Sheet > short Term Debt
1199000
Annuals > 3 > balance Sheet > long Term Debt
9622000
Annuals > 3 > balance Sheet > total Liabilities
21057000
Annuals > 3 > balance Sheet > equity
196876000
Annuals > 3 > cash Flow > net Income
-54630000
Annuals > 3 > cash Flow > depreciation
1510000
Annuals > 3 > cash Flow > change In Working Capital
1226000
Annuals > 3 > cash Flow > cash From Operations
-42437000
Annuals > 3 > cash Flow > capital Expenditures
316000
Annuals > 3 > cash Flow > cash From Investing
-28444000
Annuals > 3 > cash Flow > cash From Financing
112585000
Annuals > 3 > cash Flow > net Change In Cash
41654000
Annuals > 3 > ratios > PE
-1.0354565689654731
Annuals > 3 > ratios > PB
1.6614918882951708
Annuals > 3 > ratios > ROE
-27.748430484162622
Annuals > 3 > ratios > ROA
-25.06733720914226
Annuals > 3 > ratios > FCF
-42753000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-1.5330926522161499
Valuation > metrics > PB
0.5515982030948708
Valuation > final Score
70
Valuation > verdict
44.8% Undervalued
Profitability > metrics > ROE
-13.530418434246046
Profitability > metrics > ROA
-11.880297562988751
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.177762244504435
Risk > metrics > Interest Coverage
-21.775092936802974
Risk > final Score
-27
Risk > verdict
High
Liquidity > metrics > Current Ratio
10.0011641443539
Liquidity > metrics > Quick Ratio
10.0011641443539
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-133
Prev Risks > 1
-143
Prev Risks > 2
-162
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:39:09.378Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.53
Earnings History > 0 > eps Estimate
-1.9567
Earnings History > 0 > eps Difference
0.4267
Earnings History > 0 > surprise Percent
21.8071
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.87
Earnings History > 1 > eps Estimate
-0.28
Earnings History > 1 > eps Difference
-1.59
Earnings History > 1 > surprise Percent
-567.8571
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-18
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-2
Earnings History > 2 > eps Estimate
-2.65
Earnings History > 2 > eps Difference
0.65
Earnings History > 2 > surprise Percent
24.5283
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-12
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-3
Earnings History > 3 > eps Estimate
-2.76
Earnings History > 3 > eps Difference
-0.24
Earnings History > 3 > surprise Percent
-8.6957
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-2.78
Earnings History > 4 > eps Estimate
-3.15
Earnings History > 4 > eps Difference
0.37
Earnings History > 4 > surprise Percent
11.746
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.27
Earnings History > 5 > eps Estimate
-0.32
Earnings History > 5 > eps Difference
0.05
Earnings History > 5 > surprise Percent
15.625
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.3
Earnings History > 6 > eps Estimate
-0.33
Earnings History > 6 > eps Difference
0.03
Earnings History > 6 > surprise Percent
9.0909
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-14
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.44
Earnings History > 7 > eps Estimate
-0.38
Earnings History > 7 > eps Difference
-0.06
Earnings History > 7 > surprise Percent
-15.7895
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.32
Earnings History > 8 > eps Estimate
-0.35
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
8.5714
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.34
Earnings History > 9 > eps Estimate
-0.32
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-6.25
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.31
Earnings History > 10 > eps Estimate
-0.29
Earnings History > 10 > eps Difference
-0.02
Earnings History > 10 > surprise Percent
-6.8966
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-14
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.25
Earnings History > 11 > eps Estimate
-0.28
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
10.7143
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.25
Earnings History > 12 > eps Estimate
-0.27
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
7.4074
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.25
Earnings History > 13 > eps Estimate
-0.27
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
7.4074
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.26
Earnings History > 14 > eps Estimate
-0.28
Earnings History > 14 > eps Difference
0.02
Earnings History > 14 > surprise Percent
7.1429
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-17
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.25
Earnings History > 15 > eps Estimate
-0.3
Earnings History > 15 > eps Difference
0.05
Earnings History > 15 > surprise Percent
16.6667
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.28
Earnings History > 16 > eps Estimate
-0.26
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-7.6923
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.25
Earnings History > 17 > eps Estimate
-0.26
Earnings History > 17 > eps Difference
0.01
Earnings History > 17 > surprise Percent
3.8462
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-12
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.25
Earnings History > 18 > eps Estimate
-0.24
Earnings History > 18 > eps Difference
-0.01
Earnings History > 18 > surprise Percent
-4.1667
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.22
Earnings History > 19 > eps Estimate
-0.23
Earnings History > 19 > eps Difference
0.01
Earnings History > 19 > surprise Percent
4.3478
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.23
Earnings History > 20 > eps Estimate
-0.21
Earnings History > 20 > eps Difference
-0.02
Earnings History > 20 > surprise Percent
-9.5238
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-05
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.22
Earnings History > 21 > eps Estimate
-0.26
Earnings History > 21 > eps Difference
0.04
Earnings History > 21 > surprise Percent
15.3846
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.3
Earnings History > 22 > eps Estimate
-0.37
Earnings History > 22 > eps Difference
0.07
Earnings History > 22 > surprise Percent
18.9189
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.5
Earnings History > 23 > eps Estimate
-0.54
Earnings History > 23 > eps Difference
0.04
Earnings History > 23 > surprise Percent
7.4074
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-06
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.48
Earnings History > 24 > eps Estimate
-0.51
Earnings History > 24 > eps Difference
0.03
Earnings History > 24 > surprise Percent
5.8824
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-07
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.46
Earnings History > 25 > eps Estimate
-0.48
Earnings History > 25 > eps Difference
0.02
Earnings History > 25 > surprise Percent
4.1667
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-07
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.4
Earnings History > 26 > eps Estimate
-0.4
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
0
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-26
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.3
Earnings History > 27 > eps Estimate
-0.44
Earnings History > 27 > eps Difference
0.14
Earnings History > 27 > surprise Percent
31.8182
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-08
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.3
Earnings History > 28 > eps Estimate
-0.48
Earnings History > 28 > eps Difference
0.18
Earnings History > 28 > surprise Percent
37.5
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-09
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-3.31
Earnings History > 29 > eps Estimate
-0.52
Earnings History > 29 > eps Difference
-2.79
Earnings History > 29 > surprise Percent
-536.5385
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-24
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-4.67
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-4.67
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-21
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
0.02
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0.02
Earnings History > 31 > surprise Percent
-
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AKalamazoo Resources issues new unquoted options as part of employee incentive scheme MSN
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6
Analyst Picks
Strong Buy
3
Buy
0
Hold
3
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 66.02% of the total shares of Kezar Life Sciences Inc
1.
TANG CAPITAL MANAGEMENT LLC(9.8319%)
since
2025/06/30
2.
Suvretta Capital Management, LLC(9.7876%)
since
2025/06/30
3.
BML Capital Management LLC(8.6737%)
since
2025/06/30
4.
Avidity Partners Management LP(6.8632%)
since
2025/06/30
5.
Vanguard Group Inc(3.772%)
since
2025/06/30
6.
Orbimed Advisors, LLC(2.6314%)
since
2025/06/30
7.
Biotech Growth Ord(2.6314%)
since
2025/05/31
8.
Vanguard Total Stock Mkt Idx Inv(2.5384%)
since
2025/07/31
9.
Stonepine Capital Management Llc(2.3195%)
since
2025/06/30
10.
ADAR1 Capital Management LLC(2.0129%)
since
2025/06/30
11.
Peapod Lane Capital LLC(1.5721%)
since
2025/06/30
12.
Ikarian Capital, LLC(1.4598%)
since
2025/06/30
13.
BlackRock Inc(1.3337%)
since
2025/06/30
14.
Renaissance Technologies Corp(1.1919%)
since
2025/06/30
15.
Qiming U.S. Ventures Management, LLC(1.1316%)
since
2025/06/30
16.
Shay Capital LLC(0.9239%)
since
2025/06/30
17.
Geode Capital Management, LLC(0.8892%)
since
2025/06/30
18.
Sphera Funds Management Ltd.(0.7994%)
since
2025/06/30
19.
Two Sigma Advisers, LLC(0.7461%)
since
2025/06/30
20.
Vanguard Institutional Extnd Mkt Idx Tr(0.7174%)
since
2025/07/31
21.
Bridgeway Capital Management, LLC(0.5599%)
since
2025/06/30
22.
Bridgeway Ultra-Small Company(0.5599%)
since
2025/06/30
23.
Fidelity Extended Market Index(0.4594%)
since
2025/07/31
24.
Dimensional Fund Advisors, Inc.(0.4093%)
since
2025/06/30
25.
RBF LLC(0.3858%)
since
2025/06/30
26.
Fidelity Global Micro-Cap F(0.3066%)
since
2025/06/30
27.
iShares Micro-Cap ETF(0.1879%)
since
2025/08/31
28.
Fidelity Total Market Index(0.1467%)
since
2025/07/31
29.
DFA US Targeted Value I(0.1452%)
since
2025/07/31
30.
Extended Equity Market Fund K(0.1406%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - L(0.1271%)
since
2025/06/30
32.
Northern Trust Extended Eq Market Idx(0.1271%)
since
2025/06/30
33.
Dimensional US Targeted Value ETF(0.1232%)
since
2025/08/29
34.
Fidelity Series Total Market Index(0.1108%)
since
2025/07/31
35.
Spartan Extended Market Index Pool F(0.1091%)
since
2025/07/31
36.
Dimensional US Small Cap ETF(0.0698%)
since
2025/08/29
37.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0595%)
since
2024/12/31
38.
NT Ext Equity Mkt Idx Fd - NL(0.0576%)
since
2025/06/30
39.
DFA US Micro Cap I(0.0537%)
since
2025/07/31
40.
Vanguard Balanced Index Inv(0.0506%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.53
EPS Estimate
-1.9567
EPS Difference
0.4267
Surprise Percent
21.8071%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.